The global clinical trials supply & logistics market size is expected to reach USD 6.25 billion by 2030, registering a CAGR of 7.6% from 2024 to 2030. The rise in advanced technology and innovations in the clinical trial supply & logistics market, implementation of stringent regulations, and the rising demand for clinical trials due to the increasing prevalence of diseases such as the COVID-19 pandemic. ![Global Clinical Trial Supply & Logistics Market]( "Global Clinical Trial Supply & Logistics Market")
Initially, the COVID-19 pandemic negatively impacted the market due to disruption in the supply chain and a reduction in commercial airlines by the government to prevent the spread of the virus. However, the market soon recovered and started to grow significantly due to rising demand for the COVID-19 vaccine to prevent this disease. For instance, according to WHO, as of August 2, 2022, there are 169 vaccines in the clinical development stage and 198 vaccines in the preclinical phase.
There has been significant investment in supply chain management software by clinical trial supplies providers. Growing complexity in clinical trials and increased competition among market players are factors responsible for the adoption of new technologies in supply chain management. The need for software for inventory management, supply chain planning, and ancillary supply chain management is expected to grow, owing to the increasing adoption of new technologies by industry players.
This product will be delivered within 2 business days.
Initially, the COVID-19 pandemic negatively impacted the market due to disruption in the supply chain and a reduction in commercial airlines by the government to prevent the spread of the virus. However, the market soon recovered and started to grow significantly due to rising demand for the COVID-19 vaccine to prevent this disease. For instance, according to WHO, as of August 2, 2022, there are 169 vaccines in the clinical development stage and 198 vaccines in the preclinical phase.
There has been significant investment in supply chain management software by clinical trial supplies providers. Growing complexity in clinical trials and increased competition among market players are factors responsible for the adoption of new technologies in supply chain management. The need for software for inventory management, supply chain planning, and ancillary supply chain management is expected to grow, owing to the increasing adoption of new technologies by industry players.
Clinical Trials Supply & Logistics Market Report Highlights
- In service segment, logistics & distribution dominated the market in 2023 with a share of 25.33%. This is due to the rise in clinical trials due to COVID- 19 pandemic
- Based on phase, The phase III segment accounted for the largest revenue share in 2023
- Based on therapeutic area, cardiovascular diseases accounted for the fastest CAGR of 8.0% during the forecast period. This is due to the rise in the number of investments by market players for bringing novel and innovation to the market
- Asia-Pacific is anticipated to register the fastest growth rate of 8.1% during the forecast period. This is due to low recruitment cost, region has access to a large and diversified patient pool, and favorable policies that make the region desirable for clinical trials
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology And Scope
1.1. Market Segmentation And Scope
1.1.1. Segment Definitions
1.1.1.1. Service Segment
1.1.1.2. Phase Segment
1.1.1.3. Therapeutics Area Segment
1.1.1.4. End use segment
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List Of Primary Sources
1.11. List Of Abbreviations
1.1.1. Segment Definitions
1.1.1.1. Service Segment
1.1.1.2. Phase Segment
1.1.1.3. Therapeutics Area Segment
1.1.1.4. End use segment
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List Of Primary Sources
1.11. List Of Abbreviations
Chapter 2. Clinical Trial Supply & Logistics Market: Executive Summary
2.1. Market Snapshot
2.2. Services And Phase Snapshots
2.3. Therapeutic Area And End Use Snapshot
2.4. Competitive Landscape Snapshot
2.2. Services And Phase Snapshots
2.3. Therapeutic Area And End Use Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Clinical Trial Supply & Logistics Market Variables, Trends, & Scope
3.1. Market Segmentation And Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Technological advancements in supply chain
3.4.2. Increasing R&D investment by pharmaceutical and biopharmaceutical firms
3.4.3. Expansion of clinical trial sites
3.5. Market Restraint Analysis
3.5.1. Stringent regulation pertaining to logistics.
3.5.2. Counterfeiting of drugs
3.6. Clinical Trial Supply & Logistics Market Analysis Tools
3.6.1. Industry Analysis - Porter’s
3.6.1.1. Supplier Power
3.6.1.2. Buyer Power
3.6.1.3. Substitution Threat
3.6.1.4. Threat Of New Entrant
3.6.1.5. Competitive Rivalry
3.6.2. PESTLE Analysis
3.6.2.1. Political Landscape
3.6.2.2. Technological Landscape
3.6.2.3. Economic Landscape
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Technological advancements in supply chain
3.4.2. Increasing R&D investment by pharmaceutical and biopharmaceutical firms
3.4.3. Expansion of clinical trial sites
3.5. Market Restraint Analysis
3.5.1. Stringent regulation pertaining to logistics.
3.5.2. Counterfeiting of drugs
3.6. Clinical Trial Supply & Logistics Market Analysis Tools
3.6.1. Industry Analysis - Porter’s
3.6.1.1. Supplier Power
3.6.1.2. Buyer Power
3.6.1.3. Substitution Threat
3.6.1.4. Threat Of New Entrant
3.6.1.5. Competitive Rivalry
3.6.2. PESTLE Analysis
3.6.2.1. Political Landscape
3.6.2.2. Technological Landscape
3.6.2.3. Economic Landscape
Chapter 4. Clinical Trial Supply & Logistics: Service Estimates & Trend Analysis
4.1. Service Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Clinical Trial Supply & Logistics Market By Service Outlook
4.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
4.4.1. Logistics & Distribution
4.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
4.4.2. Storage & Retention
4.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
4.4.3. Packaging, Labeling, And Blinding
4.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
4.4.4. Manufacturing
4.4.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
4.4.5. Comparator Sourcing
4.4.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
4.4.6. Other
4.4.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
4.2. Segment Dashboard
4.3. Global Clinical Trial Supply & Logistics Market By Service Outlook
4.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
4.4.1. Logistics & Distribution
4.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
4.4.2. Storage & Retention
4.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
4.4.3. Packaging, Labeling, And Blinding
4.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
4.4.4. Manufacturing
4.4.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
4.4.5. Comparator Sourcing
4.4.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
4.4.6. Other
4.4.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 5. Clinical Trial Supply & Logistics: Phase Estimates & Trend Analysis
5.1. Phase Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Clinical Trial Supply & Logistics Market By Phase Outlook
5.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
5.4.1. Phase I
5.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
5.4.2. Phase II
5.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
5.4.3. Phase III
5.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
5.4.4. Phase IV
5.4.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
5.2. Segment Dashboard
5.3. Global Clinical Trial Supply & Logistics Market By Phase Outlook
5.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
5.4.1. Phase I
5.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
5.4.2. Phase II
5.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
5.4.3. Phase III
5.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
5.4.4. Phase IV
5.4.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 6. Clinical Trial Supply & Logistics: Therapeutic Area Estimates & Trend Analysis
6.1. Therapeutic Area Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Clinical Trial Supply & Logistics Market By Therapeutic Area Outlook
6.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
6.4.1. Oncology
6.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
6.4.2. Central Nervous System (CNS) Disorders
6.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
6.4.3. Cardiovascular Diseases
6.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
6.4.4. Respiratory Diseases
6.4.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
6.4.5. Others
6.4.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
6.2. Segment Dashboard
6.3. Global Clinical Trial Supply & Logistics Market By Therapeutic Area Outlook
6.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
6.4.1. Oncology
6.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
6.4.2. Central Nervous System (CNS) Disorders
6.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
6.4.3. Cardiovascular Diseases
6.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
6.4.4. Respiratory Diseases
6.4.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
6.4.5. Others
6.4.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 7. Clinical Trial Supply & Logistics: End Use Estimates & Trend Analysis
7.1. End use Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Global Clinical Trial Supply & Logistics Market By End use Area Outlook
7.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
7.4.1. Pharmaceutical
7.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
7.4.2. Biologicals
7.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
7.4.3. Medical Devices
7.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
7.2. Segment Dashboard
7.3. Global Clinical Trial Supply & Logistics Market By End use Area Outlook
7.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
7.4.1. Pharmaceutical
7.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
7.4.2. Biologicals
7.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
7.4.3. Medical Devices
7.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:
8.5. North America
8.5.1. U.S.
8.5.1.1. Key Country Dynamics
8.5.1.2. Competitive Scenario
8.5.1.3. Regulatory Framework
8.5.1.4. U.S. Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.5.2. Canada
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Canada Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.6. Europe
8.6.1. UK
8.6.1.1. Key Country Dynamics
8.6.1.2. Competitive Scenario
8.6.1.3. Regulatory Framework
8.6.1.4. UK Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.6.2. Germany
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Germany Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.6.3. Spain
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Spain Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.6.4. France
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. France Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.6.5. Italy
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Italy Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.6.6. Denmark
8.6.6.1. Key Country Dynamics
8.6.6.2. Competitive Scenario
8.6.6.3. Regulatory Framework
8.6.6.4. Denmark Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.6.7. Sweden
8.6.7.1. Key Country Dynamics
8.6.7.2. Competitive Scenario
8.6.7.3. Regulatory Framework
8.6.7.4. Sweden Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.6.8. Norway
8.6.8.1. Key Country Dynamics
8.6.8.2. Competitive Scenario
8.6.8.3. Regulatory Framework
8.6.8.4. Norway Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.7. Asia-Pacific
8.7.1. JAPAN
8.7.1.1. Key Country Dynamics
8.7.1.2. Competitive Scenario
8.7.1.3. Regulatory Framework
8.7.1.4. Japan Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.7.2. China
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. China Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.7.3. India
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. India Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.7.4. South Korea
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. South Korea Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.7.5. Thailand
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. Thailand Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.7.6. Australia
8.7.6.1. Key Country Dynamics
8.7.6.2. Competitive Scenario
8.7.6.3. Regulatory Framework
8.7.6.4. Australia Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.8. Latin America
8.8.1. Brazil
8.8.1.1. Key Country Dynamics
8.8.1.2. Competitive Scenario
8.8.1.3. Regulatory Framework
8.8.1.4. Brazil Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.8.2. Mexico
8.8.2.1. Key Country Dynamics
8.8.2.2. Competitive Scenario
8.8.2.3. Regulatory Framework
8.8.2.4. Mexico Clinical Trial Supply & Logistics Market, 2018-2030 (USD Million)
8.8.3. Argentina
8.8.3.1. Key Country Dynamics
8.8.3.2. Competitive Scenario
8.8.3.3. Regulatory Framework
8.8.3.4. Argentina Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.9. MEA
8.9.1. MEA Clinical Trial Supply & Logistics Market, 2018-2030 (USD Million)
8.9.2. South Africa
8.9.2.1. Key Country Dynamics
8.9.2.2. Competitive Scenario
8.9.2.3. Regulatory Framework
8.9.2.4. South Africa Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.9.3. Saudi Arabia
8.9.3.1. Key Country Dynamics
8.9.3.2. Competitive Scenario
8.9.3.3. Regulatory Framework
8.9.3.4. Saudi Arabia Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.9.4. UAE
8.9.4.1. Key Country Dynamics
8.9.4.2. Competitive Scenario
8.9.4.3. Regulatory Framework
8.9.4.4. UAE Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.9.5. Kuwait
8.9.5.1. Key Country Dynamics
8.9.5.2. Competitive Scenario
8.9.5.3. Regulatory Framework
8.9.5.4. Kuwait Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:
8.5. North America
8.5.1. U.S.
8.5.1.1. Key Country Dynamics
8.5.1.2. Competitive Scenario
8.5.1.3. Regulatory Framework
8.5.1.4. U.S. Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.5.2. Canada
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Canada Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.6. Europe
8.6.1. UK
8.6.1.1. Key Country Dynamics
8.6.1.2. Competitive Scenario
8.6.1.3. Regulatory Framework
8.6.1.4. UK Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.6.2. Germany
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Germany Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.6.3. Spain
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Spain Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.6.4. France
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. France Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.6.5. Italy
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Italy Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.6.6. Denmark
8.6.6.1. Key Country Dynamics
8.6.6.2. Competitive Scenario
8.6.6.3. Regulatory Framework
8.6.6.4. Denmark Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.6.7. Sweden
8.6.7.1. Key Country Dynamics
8.6.7.2. Competitive Scenario
8.6.7.3. Regulatory Framework
8.6.7.4. Sweden Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.6.8. Norway
8.6.8.1. Key Country Dynamics
8.6.8.2. Competitive Scenario
8.6.8.3. Regulatory Framework
8.6.8.4. Norway Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.7. Asia-Pacific
8.7.1. JAPAN
8.7.1.1. Key Country Dynamics
8.7.1.2. Competitive Scenario
8.7.1.3. Regulatory Framework
8.7.1.4. Japan Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.7.2. China
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. China Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.7.3. India
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. India Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.7.4. South Korea
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. South Korea Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.7.5. Thailand
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. Thailand Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.7.6. Australia
8.7.6.1. Key Country Dynamics
8.7.6.2. Competitive Scenario
8.7.6.3. Regulatory Framework
8.7.6.4. Australia Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.8. Latin America
8.8.1. Brazil
8.8.1.1. Key Country Dynamics
8.8.1.2. Competitive Scenario
8.8.1.3. Regulatory Framework
8.8.1.4. Brazil Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.8.2. Mexico
8.8.2.1. Key Country Dynamics
8.8.2.2. Competitive Scenario
8.8.2.3. Regulatory Framework
8.8.2.4. Mexico Clinical Trial Supply & Logistics Market, 2018-2030 (USD Million)
8.8.3. Argentina
8.8.3.1. Key Country Dynamics
8.8.3.2. Competitive Scenario
8.8.3.3. Regulatory Framework
8.8.3.4. Argentina Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.9. MEA
8.9.1. MEA Clinical Trial Supply & Logistics Market, 2018-2030 (USD Million)
8.9.2. South Africa
8.9.2.1. Key Country Dynamics
8.9.2.2. Competitive Scenario
8.9.2.3. Regulatory Framework
8.9.2.4. South Africa Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.9.3. Saudi Arabia
8.9.3.1. Key Country Dynamics
8.9.3.2. Competitive Scenario
8.9.3.3. Regulatory Framework
8.9.3.4. Saudi Arabia Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.9.4. UAE
8.9.4.1. Key Country Dynamics
8.9.4.2. Competitive Scenario
8.9.4.3. Regulatory Framework
8.9.4.4. UAE Market Estimates And Forecasts 2018 To 2030 (USD Million)
8.9.5. Kuwait
8.9.5.1. Key Country Dynamics
8.9.5.2. Competitive Scenario
8.9.5.3. Regulatory Framework
8.9.5.4. Kuwait Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company /Competition Categorization
9.3. Vendor Landscape
9.3.1. List Of Key Distributors And Channel Partners
9.3.2. Key Customers
9.3.3. Key Company Market Share Analysis, 2023
9.3.4. Thermo Fisher Scientific (Patheon)
9.3.4.1. Overview
9.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Catalent, Inc.
9.3.5.1. Overview
9.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Parexel International (MA) Corporation
9.3.6.1. Overview
9.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Almac Group
9.3.7.1. Overview
9.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Marken
9.3.8.1. Overview
9.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Piramal Pharma Solutions
9.3.9.1. Overview
9.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. UDG HEALTHCARE
9.3.10.1. Overview
9.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.10.3. Product Benchmarking
9.3.10.4. Strategic Initiatives
9.3.11. DHL
9.3.11.1. Overview
9.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.11.3. Product Benchmarking
9.3.11.4. Strategic Initiatives
9.3.12. FedEx
9.3.12.1. Overview
9.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.12.3. Product Benchmarking
9.3.12.4. Strategic Initiatives
9.3.13. Movianto
9.3.13.1. Overview
9.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.13.3. Product Benchmarking
9.3.13.4. Strategic Initiatives
9.3.14. Packaging Coordinators Inc
9.3.14.1. Overview
9.3.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.14.3. Product Benchmarking
9.3.14.4. Strategic Initiatives
9.2. Company /Competition Categorization
9.3. Vendor Landscape
9.3.1. List Of Key Distributors And Channel Partners
9.3.2. Key Customers
9.3.3. Key Company Market Share Analysis, 2023
9.3.4. Thermo Fisher Scientific (Patheon)
9.3.4.1. Overview
9.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Catalent, Inc.
9.3.5.1. Overview
9.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Parexel International (MA) Corporation
9.3.6.1. Overview
9.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Almac Group
9.3.7.1. Overview
9.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Marken
9.3.8.1. Overview
9.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Piramal Pharma Solutions
9.3.9.1. Overview
9.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. UDG HEALTHCARE
9.3.10.1. Overview
9.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.10.3. Product Benchmarking
9.3.10.4. Strategic Initiatives
9.3.11. DHL
9.3.11.1. Overview
9.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.11.3. Product Benchmarking
9.3.11.4. Strategic Initiatives
9.3.12. FedEx
9.3.12.1. Overview
9.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.12.3. Product Benchmarking
9.3.12.4. Strategic Initiatives
9.3.13. Movianto
9.3.13.1. Overview
9.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.13.3. Product Benchmarking
9.3.13.4. Strategic Initiatives
9.3.14. Packaging Coordinators Inc
9.3.14.1. Overview
9.3.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.14.3. Product Benchmarking
9.3.14.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America Clinical Trial Supply & Logistics Market, Region, 2018-2030 (USD Million)
Table 3 North America Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 4 North America Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 5 North America Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 6 North America Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 7 U.S. Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 8 U.S. Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 9 U.S. Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 10 U.S. Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 11 Canada Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 12 Canada Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 13 Canada Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 14 Canada Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 15 Europe Clinical Trial Supply & Logistics Market, Region, 2018-2030 (USD Million)
Table 16 Europe Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 17 Europe Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 18 Europe Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 19 Europe Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 20 UK Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 21 UK Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 22 UK Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 23 UK Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 24 Germany Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 25 Germany Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 26 Germany Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 27 Germany Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 28 France Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 29 France Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 30 France Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 31 France Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 32 Italy Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 33 Italy Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 34 Italy Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 35 Italy Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 36 Spain Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 37 Spain Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 38 Spain Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 39 Spain Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 40 Sweden Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 41 Sweden Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 42 Sweden Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 43 Sweden Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 44 Norway Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 45 Norway Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 46 Norway Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 47 Norway Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 48 Denmark Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 49 Denmark Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 50 Denmark Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 51 Denmark Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 52 Asia-Pacific Clinical Trial Supply & Logistics Market, Region, 2018-2030 (USD Million)
Table 53 Asia-Pacific Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 54 Asia-Pacific Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 55 Asia-Pacific Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 56 Asia-Pacific Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 57 Japan Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 58 Japan Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 59 Japan Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 60 Japan Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 61 China Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 62 China Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 63 China Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 64 China Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 65 India Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 66 India Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 67 India Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 68 India Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 69 Australia Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 70 Australia Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 71 Australia Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 72 Australia Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 73 South Korea Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 74 South Korea Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 75 South Korea Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 76 South Korea Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 77 Thailand Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 78 Thailand Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 79 Thailand Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 80 Thailand Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 81 Latin America Clinical Trial Supply & Logistics Market, Region, 2018-2030 (USD Million)
Table 82 Latin America Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 83 Latin America Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 84 Latin America Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 85 Latin America Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 86 Brazil Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 87 Brazil Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 88 Brazil Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 89 Brazil Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 90 Mexico Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 91 Mexico Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 92 Mexico Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 93 Mexico Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 94 Argentina Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 95 Argentina Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 96 Argentina Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 97 Argentina Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 98 MEA Clinical Trial Supply & Logistics Market, Region, 2018-2030 (USD Million)
Table 99 MEA Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 100 MEA Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 101 MEA Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 102 MEA Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 103 South Africa Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 104 South Africa Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 105 South Africa Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 106 South Africa Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 107 Saudi Arabia Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 108 Saudi Arabia Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 109 Saudi Arabia Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 110 Saudi Arabia Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 111 UAE Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 112 UAE Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 113 UAE Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 114 UAE Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 115 Kuwait Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 116 Kuwait Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 117 Kuwait Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 118 Kuwait Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 2 North America Clinical Trial Supply & Logistics Market, Region, 2018-2030 (USD Million)
Table 3 North America Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 4 North America Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 5 North America Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 6 North America Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 7 U.S. Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 8 U.S. Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 9 U.S. Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 10 U.S. Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 11 Canada Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 12 Canada Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 13 Canada Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 14 Canada Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 15 Europe Clinical Trial Supply & Logistics Market, Region, 2018-2030 (USD Million)
Table 16 Europe Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 17 Europe Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 18 Europe Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 19 Europe Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 20 UK Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 21 UK Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 22 UK Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 23 UK Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 24 Germany Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 25 Germany Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 26 Germany Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 27 Germany Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 28 France Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 29 France Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 30 France Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 31 France Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 32 Italy Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 33 Italy Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 34 Italy Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 35 Italy Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 36 Spain Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 37 Spain Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 38 Spain Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 39 Spain Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 40 Sweden Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 41 Sweden Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 42 Sweden Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 43 Sweden Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 44 Norway Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 45 Norway Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 46 Norway Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 47 Norway Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 48 Denmark Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 49 Denmark Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 50 Denmark Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 51 Denmark Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 52 Asia-Pacific Clinical Trial Supply & Logistics Market, Region, 2018-2030 (USD Million)
Table 53 Asia-Pacific Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 54 Asia-Pacific Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 55 Asia-Pacific Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 56 Asia-Pacific Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 57 Japan Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 58 Japan Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 59 Japan Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 60 Japan Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 61 China Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 62 China Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 63 China Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 64 China Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 65 India Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 66 India Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 67 India Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 68 India Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 69 Australia Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 70 Australia Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 71 Australia Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 72 Australia Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 73 South Korea Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 74 South Korea Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 75 South Korea Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 76 South Korea Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 77 Thailand Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 78 Thailand Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 79 Thailand Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 80 Thailand Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 81 Latin America Clinical Trial Supply & Logistics Market, Region, 2018-2030 (USD Million)
Table 82 Latin America Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 83 Latin America Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 84 Latin America Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 85 Latin America Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 86 Brazil Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 87 Brazil Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 88 Brazil Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 89 Brazil Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 90 Mexico Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 91 Mexico Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 92 Mexico Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 93 Mexico Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 94 Argentina Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 95 Argentina Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 96 Argentina Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 97 Argentina Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 98 MEA Clinical Trial Supply & Logistics Market, Region, 2018-2030 (USD Million)
Table 99 MEA Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 100 MEA Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 101 MEA Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 102 MEA Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 103 South Africa Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 104 South Africa Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 105 South Africa Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 106 South Africa Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 107 Saudi Arabia Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 108 Saudi Arabia Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 109 Saudi Arabia Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 110 Saudi Arabia Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 111 UAE Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 112 UAE Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 113 UAE Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 114 UAE Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
Table 115 Kuwait Clinical Trial Supply & Logistics Market, By Service, 2018-2030 (USD Million)
Table 116 Kuwait Clinical Trial Supply & Logistics Market, By Phase, 2018-2030 (USD Million)
Table 117 Kuwait Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018-2030 (USD Million)
Table 118 Kuwait Clinical Trial Supply & Logistics Market, By End Use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Primary Interviews In North America
Figure 5 Primary Interviews In Europe
Figure 6 Primary Interviews In APAC
Figure 7 Primary Interviews In Latin America
Figure 8 Primary Interviews In MEA
Figure 9 Market Research Approaches
Figure 10 Value-Chain-Based Sizing & Forecasting
Figure 11 QFD Modeling For Market Share Assessment
Figure 12 Market Formulation & Validation
Figure 13 Clinical Trial Supply & Logistics Market: Market Outlook
Figure 14 Clinical Trial Supply & Logistics Competitive Insights
Figure 15 Parent Market Outlook
Figure 16 Related/Ancillary Market Outlook
Figure 17 Penetration And Growth Prospect Mapping
Figure 18 Industry Value Chain Analysis
Figure 19 Clinical Trial Supply & Logistics Market Driver Impact
Figure 20 Clinical Trial Supply & Logistics Market Restraint Impact
Figure 21 Clinical Trial Supply & Logistics Market Strategic Initiatives Analysis
Figure 22 Clinical Trial Supply & Logistics Market: Service Movement Analysis
Figure 23 Clinical Trial Supply & Logistics Market: Service Outlook And Key Takeaways
Figure 24 Logistics & distribution Market Estimates And Forecast, 2018-2030
Figure 25 Storage & retention Market Estimates And Forecast, 2018-2030
Figure 26 Packaging, labeling, and blinding Market Estimates And Forecast, 2018-2030
Figure 27 Manufacturing Market Estimates And Forecast, 2018-2030
Figure 28 Comparator sourcing Market Estimates And Forecast, 2018-2030
Figure 29 Other Market Estimates And Forecast, 2018-2030
Figure 30 Clinical Trial Supply & Logistics Market: Phase Movement Analysis
Figure 31 Clinical Trial Supply & Logistics Market: Phase Outlook And Key Takeaways
Figure 32 Phase I Market Estimates And Forecasts, 2018-2030
Figure 33 Phase II Market Estimates And Forecasts, 2018-2030
Figure 34 Phase III Market Estimates And Forecasts, 2018-2030
Figure 35 Phase IV Market Estimates And Forecasts, 2018-2030
Figure 36 Clinical Trial Supply & Logistics Market: Therapeutic Area Movement Analysis
Figure 37 Clinical Trial Supply & Logistics Market: Therapeutic Area Outlook And Key Takeaways
Figure 38 Oncology Market Estimates And Forecasts, 2018-2030
Figure 39 Cardiovascular Market Estimates And Forecasts, 2018-2030
Figure 40 Respiratory disease Market Estimates And Forecasts, 2018-2030
Figure 41 CNS & Mental Disorders Market Estimates And Forecasts, 2018-2030
Figure 42 Others Market Estimates And Forecasts, 2018-2030
Figure 43 Clinical Trial Supply & Logistics Market: End Use Movement Analysis
Figure 44 Clinical Trial Supply & Logistics Market: End Use Outlook And Key Takeaways
Figure 45 Pharmaceuticals Market Estimates And Forecasts, 2018-2030
Figure 46 Biologicals Market Estimates And Forecasts, 2018-2030
Figure 47 Medical Device Market Estimates And Forecasts, 2018-2030
Figure 48 Global Clinical Trial Supply & Logistics Market: Regional Movement Analysis
Figure 49 Global Clinical Trial Supply & Logistics Market: Regional Outlook And Key Takeaways
Figure 50 Global Clinical Trial Supply & Logistics Market Share And Leading Players
Figure 51 North America Market Share And Leading Players
Figure 52 Europe Market Share And Leading Players
Figure 53 Asia-Pacific Market Share And Leading Players
Figure 54 Latin America Market Share And Leading Players
Figure 55 Middle East & Africa Market Share And Leading Players
Figure 56 North America: SWOT
Figure 57 Europe SWOT
Figure 58 Asia-Pacific SWOT
Figure 59 Latin America SWOT
Figure 60 MEA SWOT
Figure 61 North America, By Country
Figure 62 North America
Figure 63 North America Market Estimates And Forecasts, 2018-2030
Figure 64 U.S.
Figure 65 U.S. Market Estimates And Forecasts, 2018-2030
Figure 66 Canada
Figure 67 Canada Market Estimates And Forecasts, 2018-2030
Figure 68 Europe
Figure 69 Europe Market Estimates And Forecasts, 2018-2030
Figure 70 UK
Figure 71 UK Market Estimates And Forecasts, 2018-2030
Figure 72 Germany
Figure 73 Germany Market Estimates And Forecasts, 2018-2030
Figure 74 France
Figure 75 France Market Estimates And Forecasts, 2018-2030
Figure 76 Italy
Figure 77 Italy Market Estimates And Forecasts, 2018-2030
Figure 78 Spain
Figure 79 Spain Market Estimates And Forecasts, 2018-2030
Figure 80 Denmark
Figure 81 Denmark Market Estimates And Forecasts, 2018-2030
Figure 82 Sweden
Figure 83 Sweden Market Estimates And Forecasts, 2018-2030
Figure 84 Norway
Figure 85 Norway Market Estimates And Forecasts, 2018-2030
Figure 86 Asia-Pacific
Figure 87 Asia-Pacific Market Estimates And Forecasts, 2018-2030
Figure 88 China
Figure 89 China Market Estimates And Forecasts, 2018-2030
Figure 90 Japan
Figure 91 Japan Market Estimates And Forecasts, 2018-2030
Figure 92 India
Figure 93 India Market Estimates And Forecasts, 2018-2030
Figure 94 Thailand
Figure 95 Thailand Market Estimates And Forecasts, 2018-2030
Figure 96 South Korea
Figure 97 South Korea Market Estimates And Forecasts, 2018-2030
Figure 98 Australia
Figure 99 Australia Market Estimates And Forecasts, 2018-2030
Figure 100 Latin America
Figure 101 Latin America Market Estimates And Forecasts, 2018-2030
Figure 102 Brazil
Figure 103 Brazil Market Estimates And Forecasts, 2018-2030
Figure 104 Mexico
Figure 105 Mexico Market Estimates And Forecasts, 2018-2030
Figure 106 Argentina
Figure 107 Argentina Market Estimates And Forecasts, 2018-2030
Figure 108 Middle East And Africa
Figure 109 Middle East And Africa Market Estimates And Forecasts, 2018-2030
Figure 110 South Africa
Figure 111 South Africa Market Estimates And Forecasts, 2018-2030
Figure 112 Saudi Arabia
Figure 113 Saudi Arabia Market Estimates And Forecasts, 2018-2030
Figure 114 UAE
Figure 115 UAE Market Estimates And Forecasts, 2018-2030
Figure 116 Kuwait
Figure 117 Kuwait Market Estimates And Forecasts, 2018-2030
Figure 118 Market Share Of Key Market Players - Clinical Trial Supply & Logistics Market
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Primary Interviews In North America
Figure 5 Primary Interviews In Europe
Figure 6 Primary Interviews In APAC
Figure 7 Primary Interviews In Latin America
Figure 8 Primary Interviews In MEA
Figure 9 Market Research Approaches
Figure 10 Value-Chain-Based Sizing & Forecasting
Figure 11 QFD Modeling For Market Share Assessment
Figure 12 Market Formulation & Validation
Figure 13 Clinical Trial Supply & Logistics Market: Market Outlook
Figure 14 Clinical Trial Supply & Logistics Competitive Insights
Figure 15 Parent Market Outlook
Figure 16 Related/Ancillary Market Outlook
Figure 17 Penetration And Growth Prospect Mapping
Figure 18 Industry Value Chain Analysis
Figure 19 Clinical Trial Supply & Logistics Market Driver Impact
Figure 20 Clinical Trial Supply & Logistics Market Restraint Impact
Figure 21 Clinical Trial Supply & Logistics Market Strategic Initiatives Analysis
Figure 22 Clinical Trial Supply & Logistics Market: Service Movement Analysis
Figure 23 Clinical Trial Supply & Logistics Market: Service Outlook And Key Takeaways
Figure 24 Logistics & distribution Market Estimates And Forecast, 2018-2030
Figure 25 Storage & retention Market Estimates And Forecast, 2018-2030
Figure 26 Packaging, labeling, and blinding Market Estimates And Forecast, 2018-2030
Figure 27 Manufacturing Market Estimates And Forecast, 2018-2030
Figure 28 Comparator sourcing Market Estimates And Forecast, 2018-2030
Figure 29 Other Market Estimates And Forecast, 2018-2030
Figure 30 Clinical Trial Supply & Logistics Market: Phase Movement Analysis
Figure 31 Clinical Trial Supply & Logistics Market: Phase Outlook And Key Takeaways
Figure 32 Phase I Market Estimates And Forecasts, 2018-2030
Figure 33 Phase II Market Estimates And Forecasts, 2018-2030
Figure 34 Phase III Market Estimates And Forecasts, 2018-2030
Figure 35 Phase IV Market Estimates And Forecasts, 2018-2030
Figure 36 Clinical Trial Supply & Logistics Market: Therapeutic Area Movement Analysis
Figure 37 Clinical Trial Supply & Logistics Market: Therapeutic Area Outlook And Key Takeaways
Figure 38 Oncology Market Estimates And Forecasts, 2018-2030
Figure 39 Cardiovascular Market Estimates And Forecasts, 2018-2030
Figure 40 Respiratory disease Market Estimates And Forecasts, 2018-2030
Figure 41 CNS & Mental Disorders Market Estimates And Forecasts, 2018-2030
Figure 42 Others Market Estimates And Forecasts, 2018-2030
Figure 43 Clinical Trial Supply & Logistics Market: End Use Movement Analysis
Figure 44 Clinical Trial Supply & Logistics Market: End Use Outlook And Key Takeaways
Figure 45 Pharmaceuticals Market Estimates And Forecasts, 2018-2030
Figure 46 Biologicals Market Estimates And Forecasts, 2018-2030
Figure 47 Medical Device Market Estimates And Forecasts, 2018-2030
Figure 48 Global Clinical Trial Supply & Logistics Market: Regional Movement Analysis
Figure 49 Global Clinical Trial Supply & Logistics Market: Regional Outlook And Key Takeaways
Figure 50 Global Clinical Trial Supply & Logistics Market Share And Leading Players
Figure 51 North America Market Share And Leading Players
Figure 52 Europe Market Share And Leading Players
Figure 53 Asia-Pacific Market Share And Leading Players
Figure 54 Latin America Market Share And Leading Players
Figure 55 Middle East & Africa Market Share And Leading Players
Figure 56 North America: SWOT
Figure 57 Europe SWOT
Figure 58 Asia-Pacific SWOT
Figure 59 Latin America SWOT
Figure 60 MEA SWOT
Figure 61 North America, By Country
Figure 62 North America
Figure 63 North America Market Estimates And Forecasts, 2018-2030
Figure 64 U.S.
Figure 65 U.S. Market Estimates And Forecasts, 2018-2030
Figure 66 Canada
Figure 67 Canada Market Estimates And Forecasts, 2018-2030
Figure 68 Europe
Figure 69 Europe Market Estimates And Forecasts, 2018-2030
Figure 70 UK
Figure 71 UK Market Estimates And Forecasts, 2018-2030
Figure 72 Germany
Figure 73 Germany Market Estimates And Forecasts, 2018-2030
Figure 74 France
Figure 75 France Market Estimates And Forecasts, 2018-2030
Figure 76 Italy
Figure 77 Italy Market Estimates And Forecasts, 2018-2030
Figure 78 Spain
Figure 79 Spain Market Estimates And Forecasts, 2018-2030
Figure 80 Denmark
Figure 81 Denmark Market Estimates And Forecasts, 2018-2030
Figure 82 Sweden
Figure 83 Sweden Market Estimates And Forecasts, 2018-2030
Figure 84 Norway
Figure 85 Norway Market Estimates And Forecasts, 2018-2030
Figure 86 Asia-Pacific
Figure 87 Asia-Pacific Market Estimates And Forecasts, 2018-2030
Figure 88 China
Figure 89 China Market Estimates And Forecasts, 2018-2030
Figure 90 Japan
Figure 91 Japan Market Estimates And Forecasts, 2018-2030
Figure 92 India
Figure 93 India Market Estimates And Forecasts, 2018-2030
Figure 94 Thailand
Figure 95 Thailand Market Estimates And Forecasts, 2018-2030
Figure 96 South Korea
Figure 97 South Korea Market Estimates And Forecasts, 2018-2030
Figure 98 Australia
Figure 99 Australia Market Estimates And Forecasts, 2018-2030
Figure 100 Latin America
Figure 101 Latin America Market Estimates And Forecasts, 2018-2030
Figure 102 Brazil
Figure 103 Brazil Market Estimates And Forecasts, 2018-2030
Figure 104 Mexico
Figure 105 Mexico Market Estimates And Forecasts, 2018-2030
Figure 106 Argentina
Figure 107 Argentina Market Estimates And Forecasts, 2018-2030
Figure 108 Middle East And Africa
Figure 109 Middle East And Africa Market Estimates And Forecasts, 2018-2030
Figure 110 South Africa
Figure 111 South Africa Market Estimates And Forecasts, 2018-2030
Figure 112 Saudi Arabia
Figure 113 Saudi Arabia Market Estimates And Forecasts, 2018-2030
Figure 114 UAE
Figure 115 UAE Market Estimates And Forecasts, 2018-2030
Figure 116 Kuwait
Figure 117 Kuwait Market Estimates And Forecasts, 2018-2030
Figure 118 Market Share Of Key Market Players - Clinical Trial Supply & Logistics Market
Companies Mentioned
- Thermo Fisher Scientific (Patheon)
- Catalent, Inc.
- Parexel International (MA) Corporation
- Almac Group
- Marken
- Piramal Pharma Solutions
- UDG HEALTHCARE
- DHL
- FedEx
- Movianto
- Packaging Coordinators Inc
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 137 |
| Published | December 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 3.7 Billion |
| Forecasted Market Value ( USD | $ 6.25 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
